- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x MG: MAGNESIUM ION(Non-covalent)
- 8 x CA: CALCIUM ION(Non-covalent)
CA.2: 5 residues within 4Å:- Chain A: D.367, R.514, S.533, E.535, S.600
5 PLIP interactions:5 interactions with chain A- Metal complexes: A:D.367, A:R.514, A:S.533, A:E.535, A:S.600
CA.3: 6 residues within 4Å:- Chain A: Q.889, D.892, Q.893, D.895, D.897
- Chain D: N.449
5 PLIP interactions:5 interactions with chain A- Metal complexes: A:Q.889, A:D.892, A:D.895, A:D.895, A:D.897
CA.19: 5 residues within 4Å:- Chain B: D.367, R.514, S.533, E.535, S.600
5 PLIP interactions:5 interactions with chain B- Metal complexes: B:D.367, B:R.514, B:S.533, B:E.535, B:S.600
CA.20: 6 residues within 4Å:- Chain A: N.449
- Chain B: Q.889, D.892, Q.893, D.895, D.897
5 PLIP interactions:5 interactions with chain B- Metal complexes: B:Q.889, B:D.892, B:D.895, B:D.895, B:D.897
CA.33: 5 residues within 4Å:- Chain C: D.367, R.514, S.533, E.535, S.600
5 PLIP interactions:5 interactions with chain C- Metal complexes: C:D.367, C:R.514, C:S.533, C:E.535, C:S.600
CA.34: 6 residues within 4Å:- Chain B: N.449
- Chain C: Q.889, D.892, Q.893, D.895, D.897
5 PLIP interactions:5 interactions with chain C- Metal complexes: C:Q.889, C:D.892, C:D.895, C:D.895, C:D.897
CA.47: 5 residues within 4Å:- Chain D: D.367, R.514, S.533, E.535, S.600
5 PLIP interactions:5 interactions with chain D- Metal complexes: D:D.367, D:R.514, D:S.533, D:E.535, D:S.600
CA.48: 6 residues within 4Å:- Chain C: N.449
- Chain D: Q.889, D.892, Q.893, D.895, D.897
5 PLIP interactions:5 interactions with chain D- Metal complexes: D:Q.889, D:D.892, D:D.895, D:D.895, D:D.897
- 32 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)(Non-functional Binders)
POV.4: 7 residues within 4Å:- Chain A: F.306, G.310, M.314, S.317, Y.318
- Chain B: I.323
- Ligands: POV.15
Ligand excluded by PLIPPOV.5: 4 residues within 4Å:- Chain A: R.20, W.22, L.26, F.266
Ligand excluded by PLIPPOV.6: 1 residues within 4Å:- Ligands: CLR.9
Ligand excluded by PLIPPOV.7: 2 residues within 4Å:- Chain A: G.125, F.148
Ligand excluded by PLIPPOV.8: 1 residues within 4Å:- Chain A: M.21
Ligand excluded by PLIPPOV.12: 5 residues within 4Å:- Chain A: N.328
- Chain D: T.245, T.248, F.252
- Ligands: POV.49
Ligand excluded by PLIPPOV.13: 9 residues within 4Å:- Chain A: T.273, W.275, E.276, V.278, Y.279
- Chain D: E.264, T.298, L.302
- Ligands: CLR.54
Ligand excluded by PLIPPOV.14: 3 residues within 4Å:- Chain A: S.135, W.275
- Ligands: CLR.54
Ligand excluded by PLIPPOV.15: 5 residues within 4Å:- Chain A: T.245, T.248, F.252
- Chain B: N.328
- Ligands: POV.4
Ligand excluded by PLIPPOV.16: 9 residues within 4Å:- Chain A: E.264, T.298, L.302
- Chain B: T.273, W.275, E.276, V.278, Y.279
- Ligands: CLR.9
Ligand excluded by PLIPPOV.17: 3 residues within 4Å:- Chain B: S.135, W.275
- Ligands: CLR.9
Ligand excluded by PLIPPOV.21: 5 residues within 4Å:- Chain B: T.245, T.248, F.252
- Chain C: N.328
- Ligands: POV.22
Ligand excluded by PLIPPOV.22: 7 residues within 4Å:- Chain B: F.306, G.310, M.314, S.317, Y.318
- Chain C: I.323
- Ligands: POV.21
Ligand excluded by PLIPPOV.23: 4 residues within 4Å:- Chain B: R.20, W.22, L.26, F.266
Ligand excluded by PLIPPOV.24: 1 residues within 4Å:- Ligands: CLR.28
Ligand excluded by PLIPPOV.25: 2 residues within 4Å:- Chain B: G.125, F.148
Ligand excluded by PLIPPOV.26: 1 residues within 4Å:- Chain B: M.21
Ligand excluded by PLIPPOV.27: 8 residues within 4Å:- Chain B: E.264, T.298, L.302
- Chain C: T.273, W.275, E.276, Y.279
- Ligands: CLR.28
Ligand excluded by PLIPPOV.31: 1 residues within 4Å:- Ligands: CLR.28
Ligand excluded by PLIPPOV.35: 7 residues within 4Å:- Chain C: F.306, G.310, M.314, S.317, Y.318
- Chain D: I.323
- Ligands: POV.44
Ligand excluded by PLIPPOV.36: 4 residues within 4Å:- Chain C: R.20, W.22, L.26, F.266
Ligand excluded by PLIPPOV.37: 1 residues within 4Å:- Ligands: CLR.41
Ligand excluded by PLIPPOV.38: 2 residues within 4Å:- Chain C: G.125, F.148
Ligand excluded by PLIPPOV.39: 1 residues within 4Å:- Chain C: M.21
Ligand excluded by PLIPPOV.40: 9 residues within 4Å:- Chain C: E.264, T.298, L.302
- Chain D: T.273, W.275, E.276, V.278, Y.279
- Ligands: CLR.41
Ligand excluded by PLIPPOV.44: 5 residues within 4Å:- Chain C: T.245, T.248, F.252
- Chain D: N.328
- Ligands: POV.35
Ligand excluded by PLIPPOV.45: 2 residues within 4Å:- Chain D: W.275
- Ligands: CLR.41
Ligand excluded by PLIPPOV.49: 7 residues within 4Å:- Chain A: I.323
- Chain D: F.306, G.310, M.314, S.317, Y.318
- Ligands: POV.12
Ligand excluded by PLIPPOV.50: 4 residues within 4Å:- Chain D: R.20, W.22, L.26, F.266
Ligand excluded by PLIPPOV.51: 1 residues within 4Å:- Ligands: CLR.54
Ligand excluded by PLIPPOV.52: 2 residues within 4Å:- Chain D: G.125, F.148
Ligand excluded by PLIPPOV.53: 1 residues within 4Å:- Chain D: M.21
Ligand excluded by PLIP- 12 x CLR: CHOLESTEROL(Non-covalent)
CLR.9: 5 residues within 4Å:- Chain A: W.263, L.302
- Ligands: POV.6, POV.16, POV.17
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:W.263, A:L.302
CLR.10: 2 residues within 4Å:- Chain A: W.23, M.30
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:W.23, A:W.23, A:M.30
- Hydrogen bonds: A:Q.19
CLR.11: 3 residues within 4Å:- Chain A: V.97, W.100, I.169
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:V.97, A:W.100, A:W.100, A:W.100, A:I.169
CLR.28: 5 residues within 4Å:- Chain B: W.263, L.302
- Ligands: POV.24, POV.27, POV.31
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:W.263, B:L.302
CLR.29: 2 residues within 4Å:- Chain B: W.23, M.30
4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:W.23, B:W.23, B:M.30
- Hydrogen bonds: B:Q.19
CLR.30: 3 residues within 4Å:- Chain B: V.97, W.100, I.169
5 PLIP interactions:5 interactions with chain B- Hydrophobic interactions: B:V.97, B:W.100, B:W.100, B:W.100, B:I.169
CLR.41: 5 residues within 4Å:- Chain C: W.263, L.302
- Ligands: POV.37, POV.40, POV.45
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:W.263, C:L.302
CLR.42: 2 residues within 4Å:- Chain C: W.23, M.30
4 PLIP interactions:4 interactions with chain C- Hydrophobic interactions: C:W.23, C:W.23, C:M.30
- Hydrogen bonds: C:Q.19
CLR.43: 3 residues within 4Å:- Chain C: V.97, W.100, I.169
5 PLIP interactions:5 interactions with chain C- Hydrophobic interactions: C:V.97, C:W.100, C:W.100, C:W.100, C:I.169
CLR.54: 5 residues within 4Å:- Chain D: W.263, L.302
- Ligands: POV.13, POV.14, POV.51
2 PLIP interactions:2 interactions with chain D- Hydrophobic interactions: D:W.263, D:L.302
CLR.55: 2 residues within 4Å:- Chain D: W.23, M.30
4 PLIP interactions:4 interactions with chain D- Hydrophobic interactions: D:W.23, D:W.23, D:M.30
- Hydrogen bonds: D:Q.19
CLR.56: 3 residues within 4Å:- Chain D: V.97, W.100, I.169
5 PLIP interactions:5 interactions with chain D- Hydrophobic interactions: D:V.97, D:W.100, D:W.100, D:W.100, D:I.169
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tao, X. et al., Molecular structures of the human Slo1 K + channel in complex with beta 4. Elife (2019)
- Release Date
- 2019-12-25
- Peptides
- Calcium-activated potassium channel subunit alpha-1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x MG: MAGNESIUM ION(Non-covalent)
- 8 x CA: CALCIUM ION(Non-covalent)
- 32 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)(Non-functional Binders)
- 12 x CLR: CHOLESTEROL(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tao, X. et al., Molecular structures of the human Slo1 K + channel in complex with beta 4. Elife (2019)
- Release Date
- 2019-12-25
- Peptides
- Calcium-activated potassium channel subunit alpha-1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.